NEWPORT BEACH, Calif. — Baruch D. Kuppermann, MD, PhD, director of the Gavin Herbert Eye Institute at the University of California, Irvine, highlights some of the innovations and companies that have sprung out of the department at the OCTANe Medical Technology Innovation Forum here.
Month: November 2017
Optical Fiber Pajamas Light Up to Treat Jaundice in Newborns
Kids born with jaundice have to spend a good deal of time in an illuminated incubator before they can metabolize bilirubin hepatically. Nobody likes this, as the child has to be taken away from the parents to spend time inside a glass box. At the Swiss Federal Laboratories for Materials Science and Technology (Empa), a new […]
10 tips for doctors caring for families affected by Zika
Families affected by the Zika virus often experience a mix of emotions, and health care providers must offer appropriate support, David J. Schonfeld, MD, FAAP, said during the Zika Virus and Your Eyes Webinar.
“Expectant parents and parents of a newborn child are usually excited about the possibilities for the future for the new child and family, but with this excitement there is also the concern that something might compromise the health and development of the child,” said Schonfeld, a developmental-behavioral pediatrician and director of the National Center for School Crisis and
AI Reads Brainwaves to Assess Preterm Brain Maturity
Researchers at the University of Helsinki and Helsinki University Hospital have created the first AI that is capable of estimating the functional brain maturity of pre-term babies. The software interprets electroencephalography (EEG) measurements taken from preterm infants to make calculations about the brain’s functional maturity. Based on machine learning, the software calculates the brain maturity […]
Where Socioeconomic Development Lags, Vision Problems Are More Common
Low levels of socioeconomic development are closely linked with a high burden of vision impairment, a recent study involving 190 countries and territories suggests. Reuters Health Information
Hologic Releases MyoSure MANUAL for In-Office Intrauterine Tissue Removal
Hologic is releasing in the U.S. its MyoSure MANUAL device for in-office removal of intrauterine fibroids and polyps. It’s used with the company’s MyoSure hysteroscope, which provides direct visualization. The device has a blade that can be rotated a full 360° and the treatment doesn’t require cauterization. The MyoSure MANUAL doesn’t require a separate vacuum or fluid […]
Ozurdex for retinal vein occlusion approved in China
The Chinese Food and Drug Administration has approved Ozurdex to treat adults with macular edema after branch retinal vein occlusion or central retinal vein occlusion, according to a press release from Allergan.
Ozurdex (dexamethasone intravitreal implant 0.7 mg) is the first intravitreal injection approved for RVO in China, where there are approximately 7.4 million RVO patients, the release said.
“The approval of Ozurdex underscores our commitment to bring more innovative eye care solutions to tackle unmet medical needs in China. Coming next, Allergan China will be accelerating access to
Researchers Stick Microscopes Inside Mouse Brains to Watch Live Neuro Activity
Scientists at the California Institute of Technology have developed a way of implanting an optical lens directly into the amygdala of a living mouse’s brain to watch the neural activity taking place. The lens is a thin glass rod that is pushed deep into the brain, while an imaging microscope connected to it lets the scientists […]
Choosing Wisely helpful, but many physicians unaware of the campaign
While awareness of the Choosing Wisely campaign was low among physicians, a majority of those who knew of the campaign reported that it was helpful and valuable, according to data published in Health Affairs.
“Low-value care … is widespread in the United States,” Carrie H. Colla, PhD, and Alexander J. Mainor, JD, MPH, both from the Dartmouth Institute for Health Policy and Clinical Practice, wrote. “It is commonly estimated that up to 30% of care is waste, which contributes substantially to costs.”
The ABIM Foundation’s Choosing Wisely campaign was created in
VIDEO: FDA panel gives overwhelming support to Rhopressa approval
NEWPORT BEACH, Calif. — At the OCTANe Medical Technology Innovation Forum here, Tom Mitro, chief operating officer of Aerie Pharmaceuticals, discusses the recent FDA panel on Rhopressa for the treatment of glaucoma.
VIDEO: Public’s reliance on Google costs physicians time with patients
BOSTON — While the internet has been a boon in making a vast wealth of information available, it has also made a vast amount of misinformation available, which is especially problematic when patients research their medical conditions online, then bring their findings to a health care provider.
“Most of our patients are going online and [they] have preconceived notions when they come to their office visit,” David R. Stukus, MD, associate professor of pediatrics within the division of allergy/immunology, and director of the complex asthma clinic at Nationwide Children’s
New technologies allow customizable presbyopia correction
Preeya K. Gupta
NEW YORK — New presbyopia correcting technologies have allowed physicians to customize treatment plans specific to their patients, according to a speaker here.
Recent years have seen the IOL market expand and new options become available for presbyopic patients. Understanding the differences between these options, discussing them with patients while understanding what type of results those patients are looking for is paramount to success, Preeya K. Gupta, MD, said at OSN New York 2017.
“There are so many more options for presbyopia correction in our current day. It’s
Aerie Pharmaceuticals to Announce Third Quarter 2017 Financial Results and Host Conference Call on Wednesday, November 8, 2017
IRVINE, Calif.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie or the Company), announced today that its third quarter 2017 financial results will be released after the market closes on Wednesday, November 8, 2017. Following the release, the Company will host a live conference call and webcast at 5:00 p.m. Eastern Time to discuss the Company’s financial results and provide a general business update. The live webcast and a replay may be accessed by visiting the Company’s websi